Literature DB >> 12660866

Cataract in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD).

I M Russell-Eggitt1, J V Leonard, A M Lund, B Manoj, D A Thompson, A A M Morris.   

Abstract

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) is a rare metabolic disorder that can lead to acute encephalopathy, liver disease, cardiomyopathy, rhabdomyolysis, and long-term complications involving the eye and peripheral nerves. LCHADD is a peroxisome biogenesis disorder (PBD). Except for the series presented by Tyni and colleagues (Ophthalmology 1998;105:810-824), which described visually insignificant lens opacities in association with LCHADD, previous ophthalmic papers have only reported retinal complications. We report on one case with progressive asymmetrical cataract. The more mildly affected eye had a similar morphology to that previously reported and the more severely affected eye had an unusual morphology we believe is unique to LCHADD. We discuss the range of ophthalmic presentations in our cases and in the literature. The variability of the severity of ocular complications, even between eyes in one individual, makes it difficult to test the effectiveness of therapeutic options upon the ophthalmic complications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660866     DOI: 10.1076/opge.24.1.49.13890

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  1 in total

1.  Long chain fatty acid oxidation defects in children: importance of detection and treatment options.

Authors:  B Hayes; B Lynch; M O'Keefe; A A Monavari; E P Treacy
Journal:  Ir J Med Sci       Date:  2007-04-13       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.